Bionics Market Report 2025

This Bionics market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The bionics market size has grown rapidly in recent years. It will grow from $13.62 billion in 2024 to $15.01 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the increased incidence of disabilities, improved healthcare infrastructure, rising healthcare expenditures, the increasing demand for organ donors, and the rising prevalence of chronic diseases.

The bionics market size is expected to see strong growth in the next few years. It will grow to $21.9 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to customization and personalization, increasing focus on rehabilitation and improving quality of life for patients, raising public awareness and acceptance, increasing the elderly population, and a rise in the geriatric population. Major trends in the forecast period include the integration of the internet of things, advancements in artificial intelligence, wireless and miniaturized electronics, the development of more sophisticated haptic and sensory technologies, and energy harvesting technologies.

The rising prevalence of physical disabilities is expected to drive the growth of the bionics market in the coming years. Physical disabilities refer to impairments that hinder a person's ability to move, carry out physical tasks, or maintain stamina, often resulting from conditions such as osteoporosis, arthritis, or general physical deterioration. Bionics improves the quality of life for individuals with physical disabilities by replacing or enhancing lost bodily functions, boosting mobility, and promoting independence. For example, in October 2024, the UK Parliament's House of Commons Library, a government body in the UK, reported that disability rates increase with age: in 2022/23, approximately 11% of children in the UK had a disability, compared to 23% of working-age adults and 45% of those above the State Pension age. As a result, the growing prevalence of physical disabilities is set to drive the expansion of the bionics market.

Leading companies in the bionics market are focusing on developing advanced technologies, such as bionic pancreas automated insulin delivery systems, to enhance diabetes management by closely mimicking the function of a healthy pancreas. The bionic pancreas system automatically adjusts insulin delivery based on real-time glucose monitoring, aiming to replicate natural pancreatic function. For instance, in December 2023, Beta Bionics Inc., a U.S.-based biotechnology firm, introduced the iLet bionic pancreas, an advanced system designed to simplify diabetes management. This device integrates with continuous glucose monitors (CGMs) to provide real-time glucose readings and adjust insulin delivery as needed. With minimal user input required - mainly the patient’s weight - the system eliminates the need for complex calculations such as insulin-to-carb ratios. The iLet Bionic Pancreas features closed-loop functionality that autonomously manages insulin dosing, making it user-friendly and reducing the burden on both patients and healthcare providers.

In February 2024, Hanger Inc., a U.S.-based provider of orthotic and prosthetic (O&P) services and products, acquired Fillauer Companies Inc. for an undisclosed amount. This acquisition enables Hanger Inc. to expand its range of advanced prosthetic and orthotic products, enhance its technological capabilities, and broaden its market reach to offer innovative mobility solutions to patients. Fillauer Companies Inc., also based in the U.S., specializes in the development and manufacturing of bionic prosthetics and orthotics.

Major companies operating in the bionics market are Boston Scientific Corporation, Zollner Elektronik AG, Sonova Holding AG, Ottobock SE & Co. KGaA, Cochlear Limited, Bioengineering Technology Inc., Össur hf, Hanger Inc., BionX Medical Technologies Inc., DarioHealth Corp., Cyberdyne Inc., Syncardia Systems LLC, AlterG Inc., Ekso Bionics Holdings Inc., MediTouch Ltd., ReWalk Robotics Ltd., Retina Implant AG, Human Engineering, Pixium Vision, Second Sight Medical Products Inc., Bionik Laboratories Corp., Neuroprosthetics Ltd., Sierra Bionics, Vincross Inc.

North America was the largest region in the bionics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bionics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bionics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Bionics involves integrating biological systems with electronic or mechanical devices to enhance or restore bodily functions. This field merges biology and technology to create advanced prosthetics, implants, and other devices that improve or restore human capabilities.

The primary types of bionics include bionic brains, bionic hearts, bionic limbs, bionic vision, and exoskeletons. A bionic brain, for example, refers to technology that combines electronic or mechanical systems with the human brain to boost cognitive functions or restore lost abilities. This includes various fixation methods, such as implantable and external bionics, and utilizes different technologies, including mechanical and electronic bionics. These innovations are applied in fields such as healthcare and defense.

The bionics market research report is one of a series of new reports that provides bionics market statistics, including bionics industry global market size, regional shares, competitors with a bionics market share, detailed bionics market segments, market trends and opportunities, and any further data you may need to thrive in the bionics industry. This bionics market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bionics market consists of revenues earned by entities by providing services such as rehabilitation services, prosthetic design and fitting, and customization and upgrades. The market value includes the value of related goods sold by the service provider or included within the service offering. The bionics market also includes sales of products including artificial organs, sensory substitution devices, exoskeletons, and neuroprosthetics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.